TEXAS ALLERGY ASTHMA AND IMMUNOLOGY SOCIETY (EIN 760105199) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1984

Legal Domicile

Principal Officer

ANIL NANDA MD

Phone

5124516108

Tax Period

2023-01-01 to 2023-12-31

TEXAS ALLERGY ASTHMA AND IMMUNOLOGY SOCIETY, founded in 1984, is a small nonprofit that reported $669K in total revenue in fiscal year 2023. Revenue surged 26% from the prior year, signaling strong growth momentum. The organization ran a surplus of $237K, a strong 35% operating margin.

Mission

TO PROMOTE HIGH PROFESSIONAL STANDARDS IN ALLERGY AND CLINICAL IMMUNOLOGY

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $45,419

Program Service Revenue $576,550

Investment Income $42,167

Other Revenue $4,980

TOTAL REVENUE $669,116

Expense Breakdown

Grants Paid $0

Salaries & Benefits $136,360

Fundraising Expenses $0

Other Expenses $296,207

TOTAL EXPENSES $432,567

Year-over-Year Comparison

	2023	2022	Change
Revenue	$669,116	$531,088	+0.3%
Expenses	$432,567	$390,222	+0.1%
Net Income	$236,549	$140,866	+0.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

$126,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ANIL NANDA MD	PRESIDENT	5.00	Officer Director	$0	$0	$0
MIGUEL WOLBERT MD	PRESIDENT-ELECT	2.00	Officer Director	$0	$0	$0
CONNIE L MAWER	EXECUTIVE DIRECTOR	25.00	Director	$126,000	$0	$126,000
J BRETT WEST MD	AT LARGE-DIRECTOR	2.00	Director	$0	$0	$0
CARLOS J VITAL MD	DIRECTOR - POSITION 3	2.00	Director	$0	$0	$0
JUSTIN CHEN MD	DIRECTOR - POSITION 1	2.00	Director	$0	$0	$0
VIVEK RAO MD	DIRECTOR - POSITION 4	2.00	Director	$0	$0	$0
MEERA GUPTA MD	DIRECTOR - POSITION 2	2.00	Director	$0	$0	$0
KELVIN SHAW MD	SECRETARY-TREASURER	2.00	Officer Director	$0	$0	$0
OJAS PATEL MD	DIRECTOR - POSITION 5	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$669,116	$432,567	$1,189,563	$236,549
2022	$531,088	$390,222	$953,014	$140,866
2021	$257,068	$203,457	$812,148	$53,611
2020	$145,928	$125,270	$758,537	$20,658
2019	$425,985	$291,622	$737,879	$134,363
2018	$370,973	$222,495	$603,516	$148,478

TEXAS ALLERGY ASTHMA AND IMMUNOLOGY SOCIETY